Dimetotiazine

This classification denotes a histamine h1 antagonist and phenothiazine with the molecular formula C19H25N3O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1FTA475ZDB, chemically known as 10-(2-(dimethylamino)propyl)-n,n-dimethylphenothiazine-2-sulfonamide but generally known as dimetotiazine, which bears US NIH Compound Identifier 3089. European Medicines Agency schedules Dimetotiazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07182MIG. World Health Organization schedules dimetotiazine in its Anatomical Therapeutic Chemical (ATC) Classification. DIMETOTIAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimetotiazine under HS 29350090 and SITC 51580. SMILES: CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)S(=O)(=O)N(C)C)N(C)C.